Pulse Biosciences

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary Nano-Pulse Stimulation™ (NPS™) platform.

Industries

Biotechnology

Headquarters

Hayward, United States

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Kevin Danahy

CEO

Collapse

Richard Nuccitelli

Chief Science Officer

Mitchell E. Levinson

Chief Strategy Officer & Director

Darrin R. Uecker

CTO & Director

Ken Stratton

General Counsel & Corporate Secretary

Ed Ebbers

EVP & General Manager, Dermatology

David Danitz

SVP of Engineering

Edison Manuel

VP of Operations

Patty Perla

VP of Human Resources

William Knape

VP of Regulatory, Clinical & Quality Affairs

Teams

View all

Leadership Team

10 members

CEO and Executive Team

6 members

Board of Directors

6 members

Discover similar companies

Cidara Therapeutics

San Diego, United States · Post IPO Equity

Bolt Biotherapeutics

Redwood City, United States · Post IPO Equity

Translate Bio

Lexington, United States · Post IPO Equity

Sorrento Therapeutics

San Diego, United States · Post IPO Equity

Quince Therapeutics

South San Francisco, United States · Post IPO Equity

Cara Therapeutics

Stamford, United States · Post IPO Equity

Kymera Therapeutics

Watertown, United States · Post IPO Equity

Celldex Therapeutics

Hampton, United States · Post IPO Equity

Kura Oncology

San Diego, United States · Post IPO Debt

Karuna Therapeutics

Boston, United States · Post IPO Equity

OncoSec

San Diego, United States · Post IPO Equity

Otonomy

San Diego, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.